137 related articles for article (PubMed ID: 34797107)
1. Experiences of cervical cancer screening in HIV-positive women in Zimbabwe.
Mpata PC; Nkosi ZZ
Curationis; 2021 Nov; 44(1):e1-e7. PubMed ID: 34797107
[TBL] [Abstract][Full Text] [Related]
2. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of integration of cervical cancer screening into routine HIV care, associated factors and perceptions among HIV-infected women: a mixed methods study at Mbarara Regional Referral Hospital, Uganda.
Ninsiima M; Nyabigambo A; Kagaayi J
BMC Health Serv Res; 2023 Apr; 23(1):333. PubMed ID: 37013535
[TBL] [Abstract][Full Text] [Related]
4. Cervical Cancer Screening in a Human Immunodeficiency Virus Treatment Centre in Zaria North-Western Nigeria.
Yahya A; Mustapha A; Kolawole AOD; Oguntayo AO; Lawal BK
West Afr J Med; 2022 Mar; 39(3):291-298. PubMed ID: 35380751
[TBL] [Abstract][Full Text] [Related]
5. Women and health providers' perspectives on male support for cervical cancer screening in Gwanda district, Zimbabwe.
Mantula F; Toefy Y
PLoS One; 2023; 18(10):e0282931. PubMed ID: 37824479
[TBL] [Abstract][Full Text] [Related]
6. Barriers and facilitators to cervical cancer screening uptake among women in Nepal - a qualitative study.
Greibe Andersen J; Shrestha AD; Gyawali B; Neupane D; Kallestrup P
Women Health; 2020 Oct; 60(9):963-974. PubMed ID: 32643576
[TBL] [Abstract][Full Text] [Related]
7. Determinants of cervical cancer screening among women living with HIV in Zimbabwe.
Antabe R; Luginaah NA; Kangmennaang J; Mkandawire P
Health Promot Int; 2023 Aug; 38(4):. PubMed ID: 37440254
[TBL] [Abstract][Full Text] [Related]
8. Challenges and opportunities associated with cervical cancer screening programs in a low income, high HIV prevalence context.
Adedimeji A; Ajeh R; Pierz A; Nkeng R; Ndenkeh JJ; Fuhngwa N; Nsame D; Nji M; Dzudie A; Anastos KM; Castle PE
BMC Womens Health; 2021 Feb; 21(1):74. PubMed ID: 33602194
[TBL] [Abstract][Full Text] [Related]
9. Model strategies to address barriers to cervical cancer treatment and palliative care among women in Zimbabwe: a public health approach.
Tapera O; Dreyer G; Nyakabau AM; Kadzatsa W; Stray-Pedersen B; Hendricks SJH
BMC Womens Health; 2021 Apr; 21(1):180. PubMed ID: 33906670
[TBL] [Abstract][Full Text] [Related]
10. Cervical Cancer Screening among Women Receiving Antiretroviral Therapy in a Resource-Limited Environment.
New-Aaron M; Meza JL; Goedert MH; Kibusi SM; Mkhoi ML; Mayengo CD; Charles J; Shabani S; Musil KM; Cheney A; Sumba S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2035-2045. PubMed ID: 32711430
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer management in Zimbabwe (2019-2020).
Zibako P; Tsikai N; Manyame S; Ginindza TG
PLoS One; 2022; 17(9):e0274884. PubMed ID: 36129898
[TBL] [Abstract][Full Text] [Related]
13. "My husband says this: If you are alive, you can be someone…": Facilitators and barriers to cervical cancer screening among women living with HIV in India.
Kung TH; Gordon JR; Abdullahi A; Barve A; Chaudhari V; Kosambiya JK; Kumar A; Gamit S; Wells KJ
Cancer Causes Control; 2019 Apr; 30(4):365-374. PubMed ID: 30809741
[TBL] [Abstract][Full Text] [Related]
14. Individual and community-level determinants of cervical cancer screening in Zimbabwe: a multi-level analyses of a nationwide survey.
Isabirye A; Elwange BC; Singh K; De Allegri M
BMC Womens Health; 2022 Jul; 22(1):309. PubMed ID: 35879710
[TBL] [Abstract][Full Text] [Related]
15. Knowledge, facilitators and barriers to cervical cancer screening among women in Uganda: a qualitative study.
Ndejjo R; Mukama T; Kiguli J; Musoke D
BMJ Open; 2017 Jun; 7(6):e016282. PubMed ID: 28606908
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.
Fentie AM; Tadesse TB; Gebretekle GB
BMC Womens Health; 2020 Jul; 20(1):147. PubMed ID: 32677933
[TBL] [Abstract][Full Text] [Related]
17. Women diagnosed with HIV and unknown HIV status perceived susceptibility to cervical cancer and perceived benefits of cervical cancer screening in Ghana: a cross-sectional study.
Enyan NIE; Akaba S; Amoo SA
BMC Womens Health; 2021 Oct; 21(1):367. PubMed ID: 34657607
[TBL] [Abstract][Full Text] [Related]
18. Role of awareness on cervical cancer screening uptake among HIV positive women in Addis Ababa, Ethiopia: A cross-sectional study.
Emru K; Abebaw TA; Abera A
Womens Health (Lond); 2021; 17():17455065211017041. PubMed ID: 34096400
[TBL] [Abstract][Full Text] [Related]
19. Barriers to Cervical Cancer Screening Among Women Living With HIV in Low- and Middle-Income Countries: A Systematic Review.
Guillaume D; Chandler R; Igbinoba S
J Assoc Nurses AIDS Care; 2020; 31(5):497-516. PubMed ID: 32675646
[TBL] [Abstract][Full Text] [Related]
20. HIV status, knowledge and prevention of cervical cancer amongst adolescent girls and women: a secondary data analysis.
Musuka G; Mukandavire Z; Murewanhema G; Cuadros D; Mutenherwa F; Chingombe I; Eghtessadi R; Herrera H; Dzinamarira T; Mapingure MP
Pan Afr Med J; 2022; 41():262. PubMed ID: 35734312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
